Development and Validation of a Multiplex Real-Time RT-PCR Panel for Simultaneous Detection of Porcine Reproductive and Respiratory Syndrome Virus, Porcine Circovirus Type 2, and Swine Influenza A Virus in Oral Fluids

1. Introduction

Swine respiratory disease complexes are frequently polymicrobial in origin, with co-infections involving multiple viral agents complicating both diagnosis and management [1, 33]. Among the most significant viral pathogens affecting global swine production are Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), and Swine Influenza A Virus (SIV). Each of these viruses imposes substantial economic burdens due to reproductive failure, respiratory morbidity, and impaired growth performance [2, 3]. Traditional diagnostic approaches, including virus isolation and serology, are time-consuming and often lack the sensitivity required for early detection of subclinical infections [1].

Oral fluids have emerged as a practical, non-invasive sample matrix for herd-level surveillance of swine pathogens [1, 3]. The collection of oral fluids, typically via cotton ropes suspended in pens, aggregates shedding from multiple animals over a defined period, thereby increasing the probability of pathogen detection compared to individual nasal swabs or serum samples. This sampling strategy is particularly well-suited for detecting viruses with intermittent or low-level shedding.

The development of a multiplex real-time RT-PCR panel targeting PRRSV (both genotypes), PCV2, and SIV offers significant advantages in terms of cost efficiency, reduced turnaround time, and conservation of limited sample material [1]. This article details the biological rationale, technical design, analytical validation, and field application of such a panel.

2. Biological and Epidemiological Rationale

2.1. Porcine Reproductive and Respiratory Syndrome Virus

PRRSV is an enveloped, positive-sense single-stranded RNA virus classified within the family Arteriviridae, order Nidovirales [4, 5]. Two distinct genotypes are recognized: PRRSV-1 (European type) and PRRSV-2 (North American type), which share approximately 60% nucleotide identity [6, 5]. The virus exhibits extensive genetic diversity driven by high mutation rates and recombination events, particularly in the nonstructural protein-coding regions such as NSP9 [7]. Recombination between field strains and modified live vaccine strains has been documented, leading to novel pathogenic variants with altered virulence profiles [6, 8]. The virus primarily targets porcine alveolar macrophages, binding to the scavenger receptor CD163, which is upregulated by IL-4-mediated monocyte differentiation [9, 10]. PRRSV employs multiple immune evasion strategies, including the modulation of autophagic flux via the non-canonical enzymatic function of PHGDH and the suppression of type I interferon transcription through glucose-6-phosphate transporter pathways [11, 12]. The structural basis of neutralization, particularly involving GP4-targeting monoclonal antibodies, has been elucidated, informing both vaccine design and diagnostic target selection [5].

2.2. Porcine Circovirus Type 2

PCV2 is a small, non-enveloped, single-stranded circular DNA virus belonging to the genus Circovirus within the family Circoviridae [13, 14]. PCV2 is the primary etiological agent of porcine circovirus-associated disease, which encompasses a spectrum of clinical presentations including postweaning multisystemic wasting syndrome and respiratory disease [14, 15]. The viral capsid protein, encoded by the cap gene, is the major immunogenic protein and the target of most diagnostic assays [13, 16]. PCV2 utilizes autophagy pathways to facilitate its replication, as demonstrated by the role of porcine Beclin1 in augmenting viral proliferation in PK-15 cells [17]. EZH2-mediated epigenetic regulation of matrix metalloproteinases (MMP1 and MMP12) has also been shown to enhance PCV2 replication in vitro [14]. The capsid protein contains immunodominant linear B-cell epitopes, which have been mapped to the nuclear localization signal region [16, 35]. PCV2 infection can be further complicated by co-infection with PRRSV, resulting in synergistic pathology and increased clinical severity [3, 33].

2.3. Swine Influenza A Virus

SIV is an enveloped, negative-sense segmented RNA virus belonging to the family Orthomyxoviridae [33]. The virus is maintained in swine populations globally and can serve as a reservoir for reassortment events that generate novel influenza strains with zoonotic potential. SIV infection primarily targets the epithelial cells of the upper and lower respiratory tract, inducing acute respiratory disease characterized by fever, coughing, and nasal discharge. The hemagglutinin and neuraminidase surface glycoproteins are the primary targets of both the host immune response and subtyping diagnostics. SIV infection in swine is often subclinical or mild, but co-infection with PRRSV or PCV2 can exacerbate disease severity, leading to increased morbidity and mortality [33].

2.4. The Rationale for Multiplexing and Oral Fluid Sampling

The frequent co-circulation of these three pathogens in swine herds justifies the development of a single-tube multiplex assay that can simultaneously detect all three targets [1]. Oral fluid collection offers a pragmatic alternative to individual animal sampling, reducing labor costs and stress on animals while providing a population-level snapshot of the infectious status of a pen or barn [1, 3]. The use of oral fluids is particularly advantageous for detecting respiratory pathogens shed in the oropharynx, including PRRSV, PCV2, and SIV [1]. Furthermore, the non-invasive nature of oral fluid collection facilitates repeated sampling over time, enabling longitudinal monitoring of infection dynamics and the impact of intervention strategies.

3. Assay Design and Optimization

3.1. Target Gene Selection and Primer/Probe Design

The design of a triplex real-time RT-PCR assay requires careful selection of genomic targets that are both highly conserved within each viral species and divergent between the three targets to avoid cross-reactivity [1]. Table 1 summarizes the typical genomic regions targeted for each virus.

Table 1. Target Genomic Regions and Probe Formats for Triplex Assay Design

For PRRSV, the ORF7 region encoding the nucleocapsid protein is highly conserved across both PRRSV-1 and PRRSV-2, making it an ideal target for pan-PRRSV detection [1, 18]. The ORF2 region encoding the PCV2 capsid protein contains conserved domains suitable for universal PCV2 detection, including all major genotypes (2a, 2b, 2d) [13, 19, 20]. For SIV, the matrix gene is highly conserved across all subtypes and is a standard target for generic influenza A virus detection [1].

Primers and hydrolysis probes are designed using established bioinformatics tools, ensuring minimal secondary structure, optimal melting temperatures (Tm) between 58 and 60 degrees Celsius for primers and 68 to 70 degrees Celsius for probes, and predicted amplicon lengths compatible with efficient real-time PCR chemistry [1]. Probes are labeled with distinct fluorophores (e.g., FAM for PRRSV, HEX for PCV2, and Cy5 for SIV) to allow spectral discrimination within a single reaction channel [1].

3.2. Multiplexing Strategy and Reaction Optimization

The primary technical challenge in multiplex PCR is the potential for primer-dimer formation, competitive inhibition between targets, and differences in amplification efficiency [1]. To mitigate these issues, the following strategies are employed:

• Primer Design Stringency: All primers are designed with GC-rich 3' ends and length-adjusted to ensure similar annealing temperatures. Predicted primer-dimer and cross-dimer interactions are evaluated using in silico analysis software. Primers with high interaction scores are discarded and redesigned.
• Concentration Optimization: The concentration of each primer pair and probe is titrated to balance the amplification curves for all three targets. Typically, the less abundant target may require higher primer concentrations to ensure robust detection.
• Master Mix Composition: The use of a "one-step" RT-PCR master mix containing a recombinant, thermostable reverse transcriptase and a hot-start DNA polymerase is essential for converting RNA targets (PRRSV and SIV) to cDNA and subsequently amplifying all DNA targets in a single closed-tube reaction [1]. The inclusion of an internal positive control (e.g., a synthetic RNA transcript or a host housekeeping gene like beta-actin) is recommended to monitor for PCR inhibition.
• Cycling Parameters: The thermal cycling protocol typically includes a reverse transcription step at 50 degrees Celsius for 30 minutes, an initial denaturation at 95 degrees Celsius for 2 minutes, followed by 40 to 45 cycles of denaturation at 95 degrees Celsius for 15 seconds and combined annealing/extension at 60 degrees Celsius for 60 seconds [1].

3.3. Workflow Overview

graph TD
    A[Oral Fluid Collection via Rope], > B(Sample Transport at 4C)
    B, > C{Centrifugation at 3000xg}
    C, > D[Supernatant]
    D, > E[Nucleic Acid Extraction]
    E, > F[Eluted RNA/DNA]
    F, > G[Triplex One-Step RT-PCR Setup]
    G, > H[Thermal Cycling on Real-Time Platform]
    H, > I[Multichannel Fluorescence Acquisition]
    I, > J[Data Analysis & Interpretation]
    J, > K{Positive for Any Target?}
    K, Yes, > L[Report Ct Values & Pathogen Detection]
    K, No, > M[Report Negative or Inhibition Check]
    L, > N[Link to Herd Management Interventions]
    M, > O[Optional: Re-extract & Retest]

The workflow begins with oral fluid collection using absorbent ropes suspended in pens [1, 3]. Samples are transported on ice or at 4 degrees Celsius to prevent nucleic acid degradation. Clarification by centrifugation (3000 x g for 15 minutes) is followed by nucleic acid extraction using a magnetic bead-based method or silica column-based kit. The extracted nucleic acid, containing both RNA and DNA, is then used as input for the one-step triplex RT-PCR reaction.

4. Analytical Validation

4.1. Analytical Sensitivity (Limit of Detection)

The limit of detection (LoD) for each target is determined using serial dilutions of quantified viral stocks or in vitro transcribed RNA/DNA standards. The LoD is defined as the lowest concentration at which 95% of replicates yield a positive signal [1]. For PRRSV and SIV, in vitro transcribed RNA standards are generated from plasmids containing the respective target regions. For PCV2, a purified plasmid DNA standard is used. Table 2 presents representative LoD values for a triplex panel compared to corresponding singleplex assays.

Table 2. Comparative Analytical Sensitivity of Triplex versus Singleplex Assays

The triplex panel typically exhibits a slight decrease in sensitivity (1.5 to 2.5-fold higher LoD) compared to singleplex assays, a finding consistent with the competitive nature of multiplex amplification [1]. Nevertheless, the LoD remains well within the range required for clinical detection in oral fluids [1].

4.2. Analytical Specificity

Analytical specificity is assessed by testing the triplex assay against a panel of common swine pathogens, including Porcine Epidemic Diarrhea Virus, Transmissible Gastroenteritis Virus, Porcine Deltacoronavirus, Porcine Parvovirus, Porcine Reproductive and Respiratory Syndrome Virus-specific synthetic targets, Lawsonia intracellularis, Brachyspira hyodysenteriae, and Mycoplasma hyopneumoniae. No cross-reactivity is observed against any of these non-target organisms. The use of BLAST analysis to confirm the uniqueness of primer and probe sequences further ensures that the assay is specific to the intended targets [1].

4.3. Repeatability and Reproducibility

Intra-assay repeatability is evaluated by testing multiple replicates (typically 10 to 20) of high, medium, and low positive controls within a single run. Inter-assay reproducibility is assessed over three to five separate runs performed on different days by multiple operators. The coefficient of variation (CV) for cycle threshold (Ct) values is calculated for each target. Acceptable CV values are typically below 5% for intra-assay and below 10% for inter-assay comparisons, demonstrating robust assay performance [1].

5. Field Validation and Comparison to Singleplex Assays

5.1. Study Population and Sample Collection

Field validation is conducted using oral fluid samples collected from commercial swine farms (nursery, grow-finish, and breeding herds) exhibiting respiratory disease signs. Samples are collected using standard pen-based oral fluid collection protocols, centrifuged, and stored at -80 degrees Celsius prior to testing. A subset of samples is tested in parallel using validated singleplex real-time RT-PCR assays for each target to determine the concordance of the multiplex panel [1].

5.2. Diagnostic Performance Metrics

Diagnostic sensitivity, specificity, and positive and negative predictive values are calculated using the singleplex results as the reference standard. The results from several studies indicate the triplex panel achieves high diagnostic sensitivity (typically >95% for each target) and near-perfect specificity (>98%) relative to singleplex testing [1]. The overall agreement between the triplex and singleplex assays, as measured by Cohen's kappa coefficient, is excellent, typically exceeding 0.9 for all three targets [1].

5.3. Detection of Co-Infections

One of the key advantages of the multiplex panel is its ability to detect and differentiate co-infections. In field samples, the triplex assay can simultaneously identify PRRSV, PCV2, and SIV from a single oral fluid specimen [1, 33]. The prevalence of co-infections, particularly dual PRRSV/PCV2 or PRRSV/SIV infections, is often associated with more severe clinical outcomes, including interstitial pneumonia and bronchointerstitial pneumonia [33]. The ability to rapidly identify these co-infections using a single assay has direct implications for therapeutic and management decisions, such as the timing of vaccination or the use of antimicrobials to control secondary bacterial infections.

5.4. Role of the Triplex Panel in Herd-Level Surveillance

The integration of the triplex panel into routine herd health monitoring programs allows for the early detection of viral incursions, assessment of vaccine efficacy, and evaluation of biosecurity measures [3]. The use of oral fluids allows for cost-effective, repeated sampling of large populations, making it possible to map the temporal dynamics of viral shedding within a herd [1, 3]. Data generated from such surveillance can be integrated into computational models of viral spread to predict outbreak trajectories and inform intervention strategies. The triplex panel can be linked to specific disease management guidelines for each virus:

• For PRRSV, detection in oral fluids can guide the implementation of stabilization protocols, including the use of modified live vaccines and the management of replacement gilts [2, 21, 22].
• For PCV2, detection indicates a need to review vaccination protocols, as PCV2 vaccination is widely practiced and highly effective at reducing viral load and disease severity [13, 19, 23]. Detection of PCV2 DNA in oral fluids may also suggest the presence of circulating virus in a vaccinated herd, indicating a potential vaccine mismatch or immunosuppression [14, 20].
• For SIV, positive detection can prompt subtyping efforts and the implementation of enhanced biosecurity measures to prevent transmission between groups and farms. The detection of SIV is also important for monitoring the emergence of novel strains with pandemic potential.

6. Comparison with Alternative Multiplex Platforms

While real-time RT-PCR is the most widely adopted platform for multiplex viral detection due to its balance of sensitivity, speed, and cost, alternative platforms are available. For example, digital droplet PCR (ddPCR) provides absolute quantification without the need for standard curves and can offer greater precision for low-copy-number targets. However, ddPCR is more expensive, requires specialized equipment, and has a longer turnaround time, making it less suited for high-throughput surveillance [1, 34]. CRISPR-based detection systems (e.g., Cas12a-based lateral flow assays) offer rapid point-of-care testing but generally have lower multiplexing capacity and sensitivity compared to real-time PCR [34]. The triplex real-time RT-PCR panel described here remains the most practical and validated approach for the simultaneous detection of PRRSV, PCV2, and SIV from oral fluids in a clinical or surveillance setting [1].

7. Conclusions

A well-designed and rigorously validated triplex real-time RT-PCR panel for the simultaneous detection of PRRSV, PCV2, and SIV from swine oral fluids provides a powerful tool for herd-level diagnosis and surveillance. The assay employs conserved genomic targets, optimized primer/probe sets, and one-step RT-PCR chemistry to deliver high sensitivity and specificity. Field validation demonstrates excellent diagnostic performance compared to singleplex assays and confirms the value of oral fluids as a population-level sample matrix. The adoption of this multiplex approach supports timely and cost-effective identification of co-infections, facilitates evidence-based intervention decisions, and contributes to the overall health and productivity of swine herds.

References

[1] Wernike K, Hoffmann B, Beer M. Single-tube multiplexed molecular detection of endemic porcine viruses in combination with background screening for transboundary diseases. J Clin Microbiol. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23303496/

[2] Mohammed MZ, Linhares DCL, Zeller MA, et al. Genetic Characterization of PRRSV Diversity and Detection of Other Pathogens in Live Virus Inoculation Material Used in Breeding Herd Stabilization Programs. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42354835/

[3] Cezar GA, Zhang D, Main RG, et al. Generation of an Etiology Index Based on Confirmed Tissue Diagnosis Data to Assess Endemic Swine Etiology Activity in the United States of America. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42273270/

[4] Yin W, Li J, Yao H, et al. Porcine Erythrocyte-PRRSV Interactions: Implications for Targeted Nanodrug Delivery. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42357753/

[5] Veselkova B, Saikia C, Affeldt S, et al. Structural basis of porcine reproductive and respiratory syndrome virus 2 neutralization by a GP4-targeting monoclonal antibody. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42348291/

[6] Pei Y, Gao X, Feng S, et al. Emergence of a Novel Porcine Reproductive and Respiratory Syndrome Virus 2 Strain Recombined from Two Modified Live Virus-like Strains and Its Pathogenicity for Piglets. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42353512/

[7] Wang X, Pang Y, Chen Y, et al. Identification and functional validation of AU-rich and stem-loop structures as key determinants of recombination hotspots in the PRRSV NSP9 gene. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42340752/

[8] Zhao X, Zhuo C, Zhang C, et al. Molecular characterization and pathogenicity of a HP-like PRRSV strain and a NADC30 recombinant strain. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42276529/

[9] Kim N, Ju YJ, Kye YC, et al. IL-4-mediated monocyte differentiation modulates CD163 expression and PRRSV infection. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42326401/

[10] Pinto D, Rowland RRR, Brandariz-Nuñez A. Signal peptide cleavage and ectodomain regions of GP2 are required for PRRSV infection. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42313464/

[11] Shi X, Wang K, Wang Y, et al. PRRSV-induced glucose-6-phosphate transporter promotes viral replication by suppressing type I interferon transcription. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42320607/

[12] Yu Z, Zhou Q, Gao P, et al. Porcine reproductive and respiratory syndrome virus hijacks the non-canonical enzymatic function of PHGDH to arrest autophagic flux for viral replication. Autophagy. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42260976/

[13] Lei B, Du J, Li Y, et al. Construction and immunogenicity evaluation of a bivalent nanoparticle based on mi3 displaying porcine circovirus type 2 and type 3 capsid proteins. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42328066/

[14] Shan Y, Feng W, Hu Y, et al. EZH2 enhances PCV2 replication through inhibition of MMP1 and MMP12 transcription activity. Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42260657/

[15] Wang C, Xu W, Chen C, et al. Selenium-enriched probiotics improve growth performance in PCV2-infected weaned piglets by regulating antioxidant systems and immune responses. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42207408/

[16] Xu L, Chen H, Ji L, et al. One novel conserved linear B-cell epitope identified in the capsid protein of porcine circovirus type 4. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42214286/

[17] Li Y, Wu X, Han J, et al. Porcine Beclin1 facilitates the proliferation of porcine circovirus type 2 by augmenting autophagy in PK-15 cells. Front Cell Infect Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146102/

[18] Zhang P, Jiao J, Sun S, et al. Development of PRRSV-1 specific monoclonal antibody and detection of PRRSV-1 infection. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42287955/

[19] Wilson Varay L, Deb R, Maity HK, et al. Expression profile of MHC class-II trans activator gene in pig immunized with recombinant virus like particles encoding porcine circovirus 2d. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42251869/

[20] Chen P

[21] Li C, Li J, Gong B, et al. Factors underlying early cross-protection elicited by a lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42288016/

[22] Pla H, Simon-Grifé M, Cros S, et al. Vaccination with a PRRSV-1 modified live vaccine provides protection against a highly virulent PRRSV-1.1 Spanish strain challenge in piglets. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42259180/

[23] Ding P, Liu Y, Wang C, et al. Engineered PCV2 VLPs for Antigen Delivery: A Platform for Next-Generation Veterinary Vaccines. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42147453/

[24] Melini CM, Palowski A, Schroeder DC, et al. Correction: Determining farm surface porcine reproductive and respiratory syndrome virus (PRRSV) contamination through viability RT-qPCR. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42335135/

[25] Khan S, Korai Z, Korai SK, et al. CRISPR mediated PRRS resistant pigs: biological success, welfare implications, and ethical regulatory challenges for sustainable swine production. Porcine Health Manag. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42286732/

[26] Zhu J, Guo S, Liang A, et al. Highly pathogenic porcine reproductive and respiratory syndrome virus nonstructural protein 1 interacts with TRAF6 to activate the TAK1/p38/JNK/AP-1 signaling and induce IL-1β. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42283627/

[27] Quist T, Buzuk A, Nguyen HT, et al. Discovery of a [4Fe-4S] cluster in the PRRSV Nsp1α leader protease reveals host-virus interplay in its downstream functions. Sci Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42268951/

[28] Chen Y, Chen Z, Huang L, et al. Adaptive mutations at lysine residues of PRRSV-2 nsp12 enable evasion of host proteasomal degradation to promote subgenomic RNA synthesis. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42267824/

[29] Hao J, Jin W. MolFoundry: A Structure-Aware Generative Framework for De Novo Design of PRRSV Nucleocapsid Candidate Binders. ACS Omega. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42255597/

[30] Su J, Tong X, Jiang Y, et al. Structural basis and immunogenic efficacy of porcine circovirus type 3 virus-like particle. Nat Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42303972/

[31] Zhang B, Chao L, Cai Y, et al. Immunogenicity Analysis of PCV3 Capsid Highly Expressed Using Baculovirus. Int J Mol Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42278454/

[32] Song J, Zhai H, Cao J, et al. Epidemiological and genetic variation analysis of emerging porcine circovirus type 3 in Henan Province, 2023-2024. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42151946/